23 May 2013
Keywords: abraxis, completes, purchase, astrazeneca, brands, los, angeles
Article | 03 July 2006
Los Angeles, US-based Abraxis BioScience says that it has completed its acquisition of the AstraZeneca US branded anesthetic and analgesic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
© 2013 thepharmaletter.com